The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Celltrion
Incheon, South Korea
A
501-1000 Employees
2002
Key takeaway
Celltrion is a prominent biopharmaceutical company that offers comprehensive solutions throughout the biopharmaceutical process, including R&D, clinical trials, and distribution. With a strong focus on innovation and a direct sales network in major markets, Celltrion is dedicated to enhancing patient access to high-quality biologics and has several biosimilars approved by the U.S.
Reference
Product
Technology
Samyang Biopharm Corporation
Seoul, South Korea
A
1-10 Employees
-
Key takeaway
The company, Samyang Biopharmaceuticals Corporation, is focused on becoming a leading global biopharmaceutical company through continuous research and development, specializing in medical devices, pharmaceuticals, and gene therapeutics. They utilize innovative drug delivery systems and are dedicated to enhancing human health worldwide.
Reference
Core business
R&DㅣCompanyㅣSamyang Biopharm
Samyang Biopharm Company Page.
BIORCHESTRA
Chungju-si, South Korea
A
1-10 Employees
2016
Key takeaway
At BIORCHESTRA, the focus is on developing innovative RNA medicines and delivery systems that address significant unmet medical needs, particularly in neurodegenerative and rare diseases. Their advanced technology enhances the targeted delivery of RNA therapeutics to brain cells, aiming to improve the quality of life for patients.
Reference
Core business
BIORCHESTRA – Innovative RNA Therapeutics
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
ProCell Therapeutics
Seoul, South Korea
A
1-10 Employees
2005
Key takeaway
ProCell aims to become a leading player in the biopharmaceutical sector, focusing on innovative drug development and advanced delivery technologies.
Reference
Core business
프로셀테라퓨틱스
MITT,MTD,거대분자세포내전송기술보유,신약개발,바이오벤처기업,피투스킨,성장인자원료,기능성화장품,OEM,ODM
Onegene Biotechnology
Seongnam-si, South Korea
A
- Employees
2016
Key takeaway
Onegene Biotechnology is focused on advancing biopharmaceutical research and development, particularly through multi-target drug development. Their flagship program, OGB21502, is a tetraspecific drug aimed at treating NASH, highlighting their commitment to innovative therapies for complex diseases.
Reference
Core business
ONEGENE BIOTECHNOLOGY
WOOJUNG BIO, Inc.
Hwaseong-si, South Korea
A
101-250 Employees
2015
Key takeaway
The company emphasizes its commitment to reducing the risks associated with biopharmaceutical development through an open innovation model. They offer a comprehensive one-stop solution for new drug development, including rapid screening of candidates and advanced facilities for efficacy and safety evaluations.
Reference
Core business
우정바이오
실험동물실 구축사업, 병원 내 미생물 멸균 및 확산 방지 시스템 개발, 공유동물실, 분석센터, 효능평가, 안전성평가, 글로벌CRO, 신약개발 전과정 지원
Janssen Korea
Seoul, South Korea
A
- Employees
1983
Key takeaway
Janssen, backed by Johnson & Johnson, is focused on transforming lives and reinventing healthcare by addressing significant health challenges, which aligns with the innovative spirit of the biopharmaceutical sector.
Reference
Core business
Company | Janssen
Genuv
Seoul, South Korea
A
11-50 Employees
2016
Key takeaway
Genuv is a biopharmaceutical company focused on developing treatments for neurodegenerative diseases by stimulating neural stem cells and restoring central nervous system (CNS) function. Their innovative approach goes beyond conventional methods, targeting immune cells and utilizing phenotypic drug screening to discover substances that promote neuroprotection and neurogenesis.
Reference
Core business
Genuv
Biopharmaceutical company. 신약발굴 플랫폼 기술을 바탕으로 퇴행성 뇌질환, 면역질환, 암질환 등, 난치성 질환분야에서 치료제를 개발하는 연구 중심 신약 개발 기업.
DongBangFTL
Hwaseong-si, South Korea
A
51-100 Employees
1990
Key takeaway
DongBangFTL is a leading company in the Active Pharmaceutical Ingredients (API) industry, highlighting its commitment to innovative research and development. With GMP certifications from multiple countries, they emphasize their capability in delivering high-quality pharmaceutical products, which is crucial in the biopharmaceutical sector.
Reference
Core business
DongbangFTL
Sartorius Korea Biotech
Seongnam-si, South Korea
A
51-100 Employees
2005
Key takeaway
Sartorius is a biopharmaceutical specialist with a 150-year tradition in science and technology, providing integrated foundational technologies that enable biopharma companies to develop and produce biopharmaceuticals like biosimilars and vaccines safely, quickly, and cost-effectively.
Reference
Core business
싸토리우스 코리아
싸토리우스는 바이오/제약산업의 연구개발/생산설비를 위한 첨단장비와 서비스를 제공하며, 안전하고 경제적으로 생산/개발할 수 있는 솔루션을 제공합니다
Technologies which have been searched by others and may be interesting for you:
When exploring the biopharmaceutical industry in South Korea, several key considerations should be taken into account. South Korea is recognized for its robust regulatory framework, which is enforced by the Ministry of Food and Drug Safety (MFDS). Companies must navigate stringent approval processes, which can impact time-to-market for new drugs. The country boasts a strong emphasis on innovation, supported by government initiatives and investment in research and development. This creates significant opportunities, especially in areas like biologics and biosimilars, where South Korea aims to become a global leader. However, challenges such as intense competition from both domestic and international firms are prevalent. The market is characterized by rapid technological advancements and a need for continuous adaptation to maintain competitive advantages. Environmental concerns related to biopharmaceutical manufacturing processes are also critical, as companies must comply with sustainability regulations. Additionally, understanding the global market relevance is crucial, as South Korean companies are increasingly looking to expand their presence internationally. Collaborations with global partners and participation in international clinical trials are common strategies to enhance market reach and bolster innovation. Overall, a comprehensive approach that encompasses regulatory knowledge, market dynamics, and sustainability is essential for success in this thriving industry.
Some interesting numbers and facts about your company results for Biopharmaceutical
| Country with most fitting companies | South Korea |
| Amount of fitting manufacturers | 20 |
| Amount of suitable service providers | 8 |
| Average amount of employees | 51-100 |
| Oldest suiting company | 1983 |
| Youngest suiting company | 2016 |
Some interesting questions that has been asked about the results you have just received for Biopharmaceutical
What are related technologies to Biopharmaceutical?
Based on our calculations related technologies to Biopharmaceutical are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on Biopharmaceutical?
The most represented industries which are working in Biopharmaceutical are Biotechnology, Other, Medical, Pharmaceuticals, IT, Software and Services
How does ensun find these Biopharmaceutical Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
